Healthcare Equity
Polar Capital Healthcare Opportunities
Last updated: 2026-09-02
The Verdict
Polar Capital Healthcare Opportunities charges an expense ratio of 1.61%. On a $100,000 portfolio, that's $1,610 per year in fees, and it scales with the amount invested. Supreme.PM's decoded model tracked it at 90% correlation, for a flat monthly subscription that does not change with portfolio size.
Expense Ratio
1.61%
Star Rating
3/ 5
Market Beta
0.92
Model Correlation
90%
Sharpe Ratio
0.48
Max Drawdown
27.84%
Supreme.PM Cost
Flat monthly subscription
Not a percentage of your assets
Performance
Performance comparison — 1Y: Fund 22.4% vs Model 21.8%; 3Y: Fund 39.1% vs Model 43.7%; 5Y: Fund 41.6% vs Model 50.8%.
Alpha After Fees
Supreme.PM's model achieves 90% correlation with Polar Capital Healthcare Opportunities, providing similar exposure at a flat subscription cost.
Fee Analysis
Polar Capital Healthcare Opportunities charges 1.61% of assets annually. Supreme.PM charges a flat monthly subscription instead, so its cost does not rise as a portfolio grows.
Data sources: Refinitiv Lipper, SEC EDGAR Filings, Supreme.PM Analytics
Past performance does not guarantee future results. Model returns are backtested and may not reflect actual trading conditions.
Related
Healthcare Equity Category
Browse all Healthcare Equity funds
Healthcare Equity Rankings
Top-rated Healthcare Equity funds
Our Methodology
How we decode fund strategies
T. Rowe Price Health Sciences Equity Fund
3-star rated
Schroder Global Healthcare
3-star rated
AXA Framlington Health
2-star rated
Pictet-Health
1-star rated
Wellington Global Health Care Equity
2-star rated
Frequently Asked Questions
What is the expense ratio of Polar Capital Healthcare Opportunities?
Polar Capital Healthcare Opportunities has an expense ratio of 1.61%, charged as a percentage of the amount invested. Supreme.PM's decoded model is offered for a flat monthly subscription instead.
How does Supreme.PM replicate Polar Capital Healthcare Opportunities?
Supreme.PM builds a transparent, rules-based model of listed securities designed to track this fund's return profile. Over the measured period it tracked the fund closely, at 90% correlation. The model is published in full, so its positions are visible rather than disclosed with a delay.
What are the risks of fund replication?
While our models aim for high correlation, they may not perfectly match the fund's returns due to timing differences in rebalancing, transaction costs, and disclosure delays. Backtested results may not reflect future performance.
Get This Strategy
Start investing with Supreme.PM's decoded model and save on fees while capturing similar returns.